Eads & Heald Wealth Management raised its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 3.3% in the 2nd quarter, Holdings Channel reports. The firm owned 2,469 shares of the health services provider’s stock after purchasing an additional 78 shares during the quarter. Eads & Heald Wealth Management’s holdings in Cigna Group were worth $816,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC raised its stake in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after acquiring an additional 3,471,249 shares in the last quarter. Nuveen LLC purchased a new position in Cigna Group in the 1st quarter worth about $727,905,000. Price T Rowe Associates Inc. MD raised its position in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after buying an additional 1,094,327 shares during the period. GQG Partners LLC increased its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after acquiring an additional 457,052 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.70% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Report on Cigna Group
Cigna Group Stock Performance
NYSE CI opened at $311.24 on Monday. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market cap of $83.08 billion, a P/E ratio of 16.99, a PEG ratio of 0.91 and a beta of 0.45. The company’s 50-day simple moving average is $292.41 and its 200 day simple moving average is $309.65.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the business earned $6.72 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 1.9%. Cigna Group’s dividend payout ratio is presently 32.97%.
Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than Cigna Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- What is a penny stock? A comprehensive guide
- Starbucks Stock Slumps; This Competitor Shows Strength
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.